Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jan;24(1):139-49.
doi: 10.1185/030079908x253519.

Molecular basis of the potential of vitamin D to prevent cancer

Affiliations
Review

Molecular basis of the potential of vitamin D to prevent cancer

Betty A Ingraham et al. Curr Med Res Opin. 2008 Jan.

Abstract

Objective: To review current research findings in cell biology, epidemiology, preclinical, and clinical trials on the protective effects of vitamin D against the development of cancers of the breast, colon, prostate, lung, and ovary. Current recommendations for optimal vitamin D status, the movement towards revision of standards, and reflections on healthy exposure to sunlight are also reviewed. Search methodology: A literature search was conducted in April and updated in September 2007. The Medline and Web of Knowledge databases were searched for primary and review articles published between 1970 and 2007, using the search terms 'vitamin D', 'calcitriol', 'cancer', 'chemoprevention', 'nuclear receptor', 'vitamin D receptor', 'apoptosis', 'cell cycle', 'epidemiology', and 'cell adhesion molecule'. Articles that focused on epidemiological, preclinical, and clinical evidence for vitamin D's effects were selected and additional articles were obtained from reference lists of the retrieved articles.

Findings: An increasing body of research supports the hypothesis that the active form of vitamin D has significant, protective effects against the development of cancer. Epidemiological studies show an inverse association between sun exposure, serum levels of 25(OH)D, and intakes of vitamin D and risk of developing and/or surviving cancer. The protective effects of vitamin D result from its role as a nuclear transcription factor that regulates cell growth, differentiation, apoptosis and a wide range of cellular mechanisms central to the development of cancer. A significant number of individuals have serum vitamin D levels lower than what appears to protect against cancer, and the research community is currently revising the guidelines for optimal health. This will lead to improved public health policies and to reduced risk of cancer.

Conclusions: Research strongly supports the view that efforts to improve vitamin D status would have significant protective effects against the development of cancer. The clinical research community is currently revising recommendations for optimal serum levels and for sensible levels of sun exposure, to levels greater than previously thought. Currently, most experts in the field believe that intakes of between 1000 and 4000 IU will lead to a more healthy level of serum 25(OH)D, at approximately 75 nmol/L that will offer significant protection effects against cancers of the breast, colon, prostate, ovary, lungs, and pancreas. The first randomized trial has shown significant protection against breast cancer, and other clinical trials will follow and ultimately lead to improved public health policies and significantly fewer cancers.

PubMed Disclaimer

Similar articles

Cited by

  • Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review.
    Denzer N, Vogt T, Reichrath J. Denzer N, et al. Dermatoendocrinol. 2011 Jul;3(3):205-10. doi: 10.4161/derm.3.3.16519. Epub 2011 Jul 1. Dermatoendocrinol. 2011. PMID: 22110781 Free PMC article.
  • Vitamin D nutrition in pregnancy: current opinion.
    Dawodu A, Akinbi H. Dawodu A, et al. Int J Womens Health. 2013 Jun 24;5:333-43. doi: 10.2147/IJWH.S34032. Print 2013. Int J Womens Health. 2013. PMID: 23843706 Free PMC article.
  • Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
    Ong JS, Cuellar-Partida G, Lu Y; Australian Ovarian Cancer Study; Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, Bogdanova N, Dörk T, Dürst M, Hillemanns P, Runnebaum IB, Antonenkova N, Butzow R, Leminen A, Nevanlinna H, Pelttari LM, Edwards RP, Kelley JL, Modugno F, Moysich KB, Ness RB, Cannioto R, Høgdall E, Høgdall CK, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, Tworoger SS, Stampfer M, Missmer S, Bjorge L, Salvesen HB, Kopperud RK, Bischof K, Aben KK, Kiemeney LA, Massuger LF, Brooks-Wilson A, Olson SH, McGuire V, Rothstein JH, Sieh W, Whittemore AS, Cook LS, Le ND, Gilks CB, Gronwald J, Jakubowska A, Lubiński J, Kluz T, Song H, Tyrer JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, Campbell I, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Wu AH, Dansonka-Mieszkowska A, Kupryjanczyk J, Timorek A, Szafron L, Cunningham JM, Fridley BL, Winham SJ, Bandera EV, Poo… See abstract for full author list ➔ Ong JS, et al. Int J Epidemiol. 2016 Oct;45(5):1619-1630. doi: 10.1093/ije/dyw207. Epub 2016 Sep 4. Int J Epidemiol. 2016. PMID: 27594614 Free PMC article.
  • Vitamin d, sunlight and prostate cancer risk.
    Donkena KV, Young CY. Donkena KV, et al. Adv Prev Med. 2011;2011:281863. doi: 10.4061/2011/281863. Epub 2011 Jun 8. Adv Prev Med. 2011. PMID: 21991434 Free PMC article.
  • Emerging role of vitamin D in colorectal cancer.
    Kang W, Lee S, Jeon E, Yun YR, Kim KH, Jang JH. Kang W, et al. World J Gastrointest Oncol. 2011 Aug 15;3(8):123-7. doi: 10.4251/wjgo.v3.i8.123. World J Gastrointest Oncol. 2011. PMID: 22007275 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources